Snail gets Nasdaq extension to fix listing issue
Snail, Inc. has received an extension from Nasdaq to regain compliance with its continued listing standards after previously failing to meet required financial thresholds.
Rhea-AI Filing Summary
Snail, Inc. has received an extension from Nasdaq to regain compliance with its continued listing standards after previously failing to meet required financial thresholds. Nasdaq requires at least $500,000 in net income from continuing operations in the most recent year or two of the last three, or alternatives based on market value or equity.
The company reported net income from continuing operations only in 2024, with net losses in 2023 and 2025, and it also did not meet Nasdaq’s market value or minimum stockholders’ equity standards. Nasdaq accepted Snail’s compliance plan and granted until September 22, 2026 to evidence compliance or face potential delisting of its Class A common stock.
Snail expects to implement its plan, which may involve equity financing and/or debt conversion or similar transactions, but there is no assurance it will successfully regain compliance. For now, the Class A common stock continues to trade on The Nasdaq Capital Market while the company works to satisfy all continued listing requirements.
Positive
- None.
Negative
- Nasdaq deficiency and delisting risk: Snail, Inc. is not in compliance with Nasdaq’s net income, market value, or stockholders’ equity continued listing standards and must regain compliance by September 22, 2026, or its Class A common stock could be subject to delisting.
Insights
Nasdaq noncompliance with a defined cure deadline adds listing risk.
Snail, Inc. has fallen short of Nasdaq’s net income, market value, and stockholders’ equity requirements. Net income from continuing operations met the standard only in 2024, with losses in 2023 and 2025, and alternative standards were also not satisfied.
Nasdaq’s acceptance of the compliance plan and the cure deadline of September 22, 2026 keep the Class A common stock trading for now, but delisting risk remains if compliance is not demonstrated in the quarterly report for the period ending September 30, 2026.
The company may pursue equity financing and/or debt conversion or similar transactions to meet the “Nasdaq Requirements.” Execution of these actions, their scale, and market reception will determine whether the company can restore compliance within the allotted timeframe.
8-K Event Classification
Key Figures
Key Terms
Deficiency Letter regulatory
Nasdaq Requirements regulatory
continued listing standards regulatory
equity financing financial
debt conversion arrangements financial
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq listing issue did Snail, Inc. (SNAL) disclose?
What are the specific Nasdaq financial requirements affecting Snail, Inc. (SNAL)?
How long does Snail, Inc. (SNAL) have to regain Nasdaq compliance?
Is Snail, Inc. (SNAL) still trading on The Nasdaq Capital Market?
What steps might Snail, Inc. (SNAL) take to regain Nasdaq compliance?
Why did Snail, Inc. (SNAL) fail the Nasdaq net income requirement?
AI-generated analysis. How Rhea-AI works. Not financial advice.